XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS’ (DEFICIT) EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Cumulative-effect adjustment
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative-effect adjustment
Beginning balance (in shares) at Dec. 26, 2021     109,345,697      
Beginning balance at Dec. 26, 2021 $ 653,117 $ (4,944) $ 109 $ 1,129,224 $ (476,216) $ (4,944)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (49,652)       (49,652)  
Exercise of stock options (in shares) 153,158   153,158      
Exercise of stock options $ 849   $ 1 848    
Exercise of common stock warrants (in shares)     12,500      
Issuance of common stock related to restricted shares 0     0    
Stock-based compensation expense 22,165     22,165    
Ending balance (in shares) at Mar. 27, 2022     109,511,355      
Ending balance at Mar. 27, 2022 $ 621,535   $ 110 1,152,237 (530,812)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-02 [Member]          
Beginning balance (in shares) at Dec. 25, 2022     111,132,993      
Beginning balance at Dec. 25, 2022 $ 541,226   $ 111 1,212,716 (671,601)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (33,657)       (33,657)  
Exercise of stock options (in shares) 160,964   160,964      
Exercise of stock options $ 767   $ 0 767    
Issuance of common stock related to restricted shares (in shares)     155,558      
Shares repurchased for employee tax withholding (6,013)          
Shares repurchased for employee tax withholding $ (44)          
Stock-based compensation expense 14,265     14,265    
Ending balance (in shares) at Mar. 26, 2023     111,443,502      
Ending balance at Mar. 26, 2023 $ 522,557   $ 111 $ 1,227,704 $ (705,258)